Wegovy Treatment in Subang Jaya | Medical Weight Management at Sheen Clinic

Struggling with weight despite dieting and exercise?
Wegovy® (semaglutide) is a prescription medication used for chronic weight management in adults with obesity or weight-related medical conditions.

At Sheen Clinic in Subang Jaya, Wegovy treatment is provided under medical supervision with structured monitoring, lifestyle guidance, and individualised dose adjustment.

Real patient after Weight loss injection treatment

What Is Wegovy?

Wegovy® contains semaglutide 2.4 mg, a GLP-1 receptor agonist approved for chronic weight management.

It works by:

• Reducing appetite

• Increasing satiety (feeling full)

• Slowing gastric emptying

• Helping regulate calorie intake

Wegovy is administered as a once-weekly subcutaneous injection.

 

Who Is Wegovy Suitable For?

Wegovy may be appropriate for:

• Adults with BMI ≥30 kg/m² (obesity)

• Adults with BMI ≥27 kg/m² with weight-related conditions such as:

  • Hypertension

  • Type 2 diabetes

  • Dyslipidaemia

  • Obstructive sleep apnoea

Eligibility is determined after medical assessment.

When Should a Patient Consider Wegovy?

You may consider Wegovy if:

• Diet and exercise alone have not resulted in sustainable weight loss

• You experience persistent hunger or cravings

• You have weight-related medical conditions

• You need medically supervised weight management

• Lifestyle programs alone have been insufficient

Wegovy is not intended for cosmetic weight loss in individuals with normal BMI.

How Does Wegovy Work?

Semaglutide mimics the hormone GLP-1 (glucagon-like peptide-1).

Mechanism of action:

• Activates GLP-1 receptors in the brain

• Reduces appetite signals

• Increases satiety

• Lowers caloric intake

• Supports gradual, sustained weight reduction

Weight loss typically occurs progressively over several months.

Expected Results

Clinical trials have shown:

• Significant percentage body weight reduction over 68 weeks

• Greater weight loss compared to lifestyle intervention alone

• Improvement in cardiometabolic risk factors

Individual results vary depending on:

• Adherence

• Lifestyle habits

• Metabolic factors

• Baseline weight

Weight management is a long-term strategy.

Treatment Protocol at Sheen Clinic

Wegovy is initiated gradually to minimise side effects.

Typical dose escalation:

• 0.25 mg weekly (starting dose)

• Gradual increase every 4 weeks

• Target maintenance dose: 2.4 mg weekly

Monitoring includes:

• Weight tracking

• Blood pressure

• Metabolic parameters (if indicated)

• Side effect assessment

Lifestyle guidance is provided alongside medication.

Common Side Effects

Most side effects are gastrointestinal and temporary:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Reduced appetite

These symptoms are usually more common during dose escalation.

Seek medical advice if experiencing:

• Persistent severe abdominal pain

• Signs of pancreatitis

• Severe dehydration
  
  

Contraindications

Wegovy is not suitable for:

• Pregnancy or breastfeeding

• Personal or family history of medullary thyroid carcinoma

• Multiple endocrine neoplasia syndrome type 2 (MEN 2)

• History of severe hypersensitivity to semaglutide

A full medical history is required before prescribing.

Frequently Asked Questions

How quickly does Wegovy work?

Appetite reduction may begin within weeks. Noticeable weight reduction typically develops over several months.

How much weight can I lose?

Clinical studies show average weight loss of approximately 10–15% of body weight over extended treatment periods, though results vary.

Do I need to exercise while on Wegovy?

Yes. Wegovy works best when combined with dietary changes and physical activity.

Is Wegovy permanent?

Weight regain may occur if medication is discontinued without maintaining lifestyle changes.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but Wegovy is specifically approved at higher doses for chronic weight management.

Safety and Medical Supervision

Wegovy is a prescription-only medication and must be administered under medical supervision.

Safe treatment requires:

• Proper patient selection

• Gradual dose escalation

• Monitoring for side effects

• Ongoing follow-up

Unsupervised use increases risk of complications.


Patient Testimonial and experience
Picture show real patient google screenshoot where her weight reduce 10kg

Wegovy Treatment in Subang Jaya

Sheen Clinic is located in Subang Jaya and serves patients from:

• USJ

• Sunway

• Puchong

• Shah Alam

• Kuala Lumpur

Regular follow-up is important for safe, effective weight management.

Quick Clinical Summary 

Treatment: Wegovy (semaglutide 2.4 mg)
Indication: Chronic weight management in adults with obesity or overweight with comorbidities
Mechanism: GLP-1 receptor agonist reducing appetite and caloric intake
Administration: Once-weekly subcutaneous injection
Dose escalation: Gradual increase to 2.4 mg
Common side effects: Nausea, vomiting, gastrointestinal symptoms
Monitoring: Medical supervision required

Consultation

Patients interested in Wegovy treatment in Subang Jaya may schedule a medical consultation for eligibility assessment and personalised weight management planning.

Book Your Consultation

If you are searching for Sunspot removal treatment in Subang Jaya, schedule a consultation to determine whether this treatment is suitable for your skin condition.

📞 Contact Us: +60122828493
🌐 Website: Sheen Clinic
📍 Locations: Subang Jaya & Kuala Lumpur, Malaysia

 

Chronic weight management requires long-term strategy, medical guidance, and lifestyle support.